Goldman Sachs has reined in risk-taking due to market volatility triggered by Donald Trump’s trade war and fears that rising ...

Goldman Sachs analysts led by Steven Kron share the firm's latest conviction list, which includes 23 of the bank's top picks ...

The housing market remains constrained in 2025. Goldman said mortgage rates will stay elevated, raising its year-end target ...

Goldman Sachs has moderated its risk-taking since U.S. President Donald Trump's April tariff announcement, and the Wall ...

Santanu Sengupta, Chief India Economist at Goldman Sachs, says the RBI is unlikely to opt for a supersized rate cut in June, ...

James Reynolds, global co-head of private credit at Goldman Sachs Asset Management discusses the state of private credit and ...

Bayer upgraded to Buy at Goldman Sachs, saying risk/reward into H2 2025 looks positive and catalysts including upcoming ...

Goldman Sachs upgrades Yum! Brands to Buy, citing Taco Bell's value leadership, strong franchise model, and plans for global ...

Goldman Sachs took a look at rising bond yields and concluded that they’re still not a threat to the S&P 500 this year.

Hedge funds bought global equities last week at the quickest pace since November 2024, Goldman Sachs said in a note, just as ...

(Reuters) - Goldman Sachs anticipates the eight country OPEC+ oil group will implement a final 0.41 million barrels per day ...

Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...